Trial site
Nowe Zdrowie-CK Kieltucki I Wspolnicy Sp. j.
- 10running trials
- 8closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis11 trials
- Crohn's disease4 trials
- Obesity2 trials
- Atrial fibrillation1 trial
- Stroke1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 310 trials
- Phase 28 trials
- Status
- Completed8 trials
- Recruiting5 trials
- Active, not recruiting4 trials
- Not yet recruiting1 trial
- Lead sponsor
- Abivax S.A.2 trials
- Cinclus Pharma Holding AB2 trials
- Hoffmann-La Roche2 trials
- Spyre Therapeutics, Inc.2 trials
- Amgen1 trial
- and 9 more
Running trials
Recruiting
Enrolling by invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Recruiting
A Phase 2 Platform Study to Evaluate Therapies for Inflammatory Bowel Disease
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ulcerative colitis4 recruiting
- Crohn's disease2 recruiting
Closed trials
Withdrawn
Completed
Active, not recruiting
A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)
Completed
Completed
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Completed
Completed
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
Completed
A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
Site data: ClinicalTrials.govUpdated 18 Nov 2026